English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Monday, April 1, 2024
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Thursday, March 28, 2024
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
Sunday, February 4, 2024
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)
Tuesday, January 2, 2024
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
Wednesday, December 13, 2023
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575